The objective was to examine whether there were causal links between vitamin D status, parathyroid hormone, insulin resistance (IR)/insulin sensitivity (IS) and the metabolic syndrome (MS). A total of 72 Caucasian men and women, aged 55.7 ± 7.57 years, with body mass index 33.4±4.02 kg/m 2 and abdominal obesity, were assessed for IR/IS based on three commonly used indices before and after 12 weeks of supervised weight loss. During weight stability, though both lower intact parathyroid hormone (iPTH) and higher vitamin D were independently associated with greater IS/lower IR, this was consistent for iPTH across the surrogate measures tested. Higher iPTH, but not lower vitamin D, increased the risk of MS after adjustment for IR/IS. Weight loss resulted in significant reductions in percent fat (À2.83±2.20%), waist (À9.26±5.11 cm), improvements in all IS indices, reductions in MS and iPTH (À0.28 ± 1.17 pmol/l), but no increase in vitamin D ( þ 2.19 ± 12.17 nmol/l). Following weight loss, DiPTH either predicted change in IR/IS or contributed to their variance by 4.1-8.9%. On adjustment for IR/IS, higher DiPTH did not significantly predict MS after weight loss, though the odds ratios for the effect were sizeable. The data are suggestive of an intrinsic inverse relationship between iPTH and IS in abdominally obese individuals, independent of vitamin D. There remains the possibility of a direct relationship between iPTH and MS.
Introduction
Australia has a very high prevalence of obesity and type 2 diabetes. Despite abundant sunshine, many Australian adults are vitamin D deficient (Nowson and Margerison, 2002) , and have lower than recommended dietary intakes of calcium. Dietary calcium and vitamin D influence human energy balance, vascular function and type 2 diabetes (Pittas et al., 2007; Soares and Chan She-Ping-Delfos, 2010; , and vitamin D may prevent many chronic diseases (Peterlik and Cross, 2009) . Hence, the coexistence of poor calcium status, abdominal obesity, vitamin D inadequacy and relative parathyroid hormone (PTH) excess needs to be addressed as a public health priority.
There has been a flurry of inquiry in this area and crosssectional studies show a significant inverse relationship between vitamin D and insulin resistance (IR) (Lee et al., 2009) , with a similar link with metabolic syndrome (MS) (Pittas et al., 2007; Ford et al., 2009; Lee et al., 2009; Kim et al., 2010) . A direct relationship between PTH and IR or MS (Reis et al., 2007; Hjelmesaeth et al., 2009) has also been observed. Still others reported a gender bias or no relationship between these hormones and IR or MS (Reis et al., 2007; Rueda et al., 2008; Del Gobbo et al., 2011) . There are many surrogate measures of IR/sensitivity that can be derived from fasting variables or following an oral glucose tolerance test. These measures are valid in their ability to predict metabolic risk, in comparison to more invasive techniques (Lerman et al., 2003; Lorenzo et al., 2010) . However, in longitudinal studies assessing change in insulin sensitivity (IS), their validity is debateable (Buchanan et al., 2010) . The underlying rationale of this analysis was if vitamin D or intact parathyroid hormone (iPTH) were independently related to IR or MS, then the relationship should hold true following a change in these variables and be consistent for each surrogate measure of IR/IS.
Subjects and methods
A total of 72 Caucasian adults with abdominal obesity were used for this analysis. They had a mean±s.d. age of 56±7.57 years, body mass index 33.4 ± 4.02 kg/m 2 , percent fat 38.8±7.56, 25-hydroxyvitamin D 59.6±17.05 nmol/l and iPTH 4.69±1.96 pmol/l. They were participants in two separate, randomized controlled trials of 12-week duration conducted in our laboratory after approval from the Human Research Ethics Committee of Curtin University. Caloric restriction in both studies was individualized for each subject based on measured BMR and an activity factor (Cummings, 2006; Chan She Ping-Delfos, 2009 ). All measurements reported here as well as body composition from Dual energy X-ray absorptiometry (DPX-L or Prodigy Models, Lunar Corporation, Madison, WI, USA), were measured using a standard protocol that emphasized an overnight fast, abstinence for 24-36 h from heavy physical activity and mandatory 30 min rest in the supine position. We used fasting values to calculate homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) , IS index (ISI) (McAuley et al., 2001 ) and HOMA2-%B and HOMA2-%S (Wallace et al., 2004) . Presence of the MS was determined from recent criteria advocated by an expert consultation (Alberti et al., 2009 ).
Statistics and analysis
All variables were normally distributed, except HOMA-IR and HOMA2-%B, which were log transformed before analysis. Partial correlations, multiple linear regression and binomial logistic regression (PASW Statistics 18, Release Version 18.0.1, SPSS, Inc., Chicago, IL, USA, http://www.spss.com), were used to determine associations before and after weight loss. Exploratory analysis forced, in order, vitamin D and iPTH into the model while testing different regression methods for entry and removal of other potential explanatory variables. Results reported here are for models that explained the greatest variance in the dependent variable. Multicollinearity analysis indicated that tolerance was always 40.2 and variable inflation factor was always o2.0 for all predictor variables in the final model.
Results
Adjusted for age, gender and season, partial correlations showed 25-hydroxyvitamin D to be significantly related to body mass index (r ¼ À0.37, Table 2 ). Weight loss resulted in significant reductions in percent fat (À2.83 ± 2.2%), waist (À9.3 ± 5.11 cm), iPTH (À0.28 ± 1.17 pmol/l), improvements in all IS indices, reductions in proportion of MS (24/72, w 2 -test, P ¼ 0.005), but no increase in vitamin D ( þ 2.2 ± 12.17 nmol/l) was noted. Change in iPTH following weight loss (DiPTH) was inversely related to IS or made significant contributions to its variance ( Table 1) . Presence of MS adjusted for IR/IS, was not significantly predicted by DiPTH despite odds ratios for the effect being sizeable (Models 3-5, Table 2 ).
Discussion
The outcomes of the analysis support findings in the literature that greater adiposity in weight-stable individuals is associated with a low vitamin D and a higher iPTH status. Interestingly, we document that higher vitamin D and lower iPTH increased IS, independent of each other. Although this is keeping with some studies (Ford et al., 2009; Lee et al., 2009; Kim et al., 2010) , the outcomes depended on the surrogate measure used (Models 1-3, Table 1 ). iPTH predicted IR/IS or made significant contributions to their variance (from 6.1 to 10.7%) across all surrogate measures. In contrast vitamin D was only related to ISI and contributed 5.8% to its variance (Table 1) . Mechanistically, IR is expected to underscore many of the abnormalities seen in MS (Alberti et al., 2009) . However, even on adjusting for IR/IS, a higher iPTH significantly increased the odds of MS (Models 1 and 2, Table 2 ). Although confirming that IR does not necessarily Corresponding IR/IS, Vit. D and iPTH in that order, were forced into model as first steps. Age, sex, season@start (0 ¼ winter, 1 ¼ spring), %FM (percent fat mass) and %FFM (percent fat-free mass) were then included in the full model and backward elimination procedure was applied to obtain the final model, using 5% critical value of w 2 -test for the appropriate degrees of freedom (d.f.).
e Analysis on subjects who had metabolic syndrome before weight loss. Corresponding changes in IR (insulin resistance)/IS (insulin sensitivity), DVit. D and DiPTH in that order, were forced into model as first steps. Age, sex, season@end (0 ¼ winter, 1 ¼ autumn), D%FM and D%FFM were then included in the full model and then backward elimination procedure was applied to obtain the final model, using 5% critical value of w 2 -test for the appropriate degrees of freedom.
account for all of MS (O'Dea and Rowley, 2002; Lerman et al., 2003; Buchanan et al., 2010) , these outcomes suggest an independent effect of iPTH on many of the components of MS.
From a causative perspective, it was important to observe whether changes in vitamin D status or in iPTH were also independent predictors of change in IR or MS. We utilized a period of weight loss as a maneuver for improving IR and MS, and explored the relationship between the changes in these variables. For each surrogate measure of IR/IS, we forced both change in vitamin D and iPTH, in that order, into the regression analysis as they were of primary interest. The outcomes suggested that DiPTH, rather than Dvitamin D (Models 4-6, Table 1 ) was consistently related to DIR/IS either as a significant predictor of that model or by making a significant contribution to the overall variance (Models 4-6, Table 1 ). This would strongly suggest that PTH has an intrinsic inverse relationship to IS, independent of vitamin D. Our estimates indicate DiPTH accounts for B4-9 % of the change in IR/IS, depending on the surrogate index (Models 4-6, Table 1 ). On further adjustment of IR/IS we did not observe a significant effect of iPTH on the presence of MS. The sizeable odds ratios could be indicative of an effect (Table 2 ), but the large 95% confidence intervals precluded a statistical effect. If confirmed, iPTH could have role in IR and MS, independent of each other.
That vitamin D was without effect was unexpected. In part, this may relate to significant decrease in iPTH during weight loss with no demonstrable differences in vitamin D. A seasonal effect, with spring having lesser IR than winter (Model 1, Table 1 ), and that older subjects had lower IS (Model 3, Table 1 ) are suggestive of vitamin D effects. There are some caveats to our observations. The duration of intervention was short and the sample size can be expected to detect only moderate to large effects (Field, 2007) . As weight loss is a powerful approach to reducing IR, any potential benefit of vitamin D may have been masked, or too small to be detected by these surrogate markers. Von-Hurst et al. (2010) have demonstrated that both, the duration (B6 months) and specific plasma concentration (B80 nmol/ l), are required before significant changes in fasting indices, like HOMA-IR, are observed. This may explain why Tai et al. (2008) and Nagpal et al. (2008) could not document any effect of vitamin D on fasting IR, though in the latter study postprandial IS did improve. In conclusion our data indicate that iPTH is intrinsically related to IR/IS and this observation is consistent across the surrogate measures studied. There was some suggestion that iPTH may also influence MS over and above the contribution of IR/IS. Confirmation of these outcomes is important to nutrition science, as there are other dietary approaches (calcium/ phosphorus) to reducing higher circulating PTH, besides improving vitamin D status.
